Guanze Medical Faces Unconditional Cash Offer at HK$0.25 per Share from Funde (Hong Kong) Investment Holdings

Guanze Medical Information Industry (Holding) Co., Ltd. (“Guanze Medical”) has released the Form of Acceptance for an unconditional mandatory cash offer issued by FUNDE (HONG KONG) Investment Holdings Co., Limited (“Funde HK”). Key details are as follows:

• Offer structure and price – Funde HK, through Aristo Securities as its agent, is offering HK$0.25 in cash for every ordinary share of HK$0.01 each in Guanze Medical. – The offer is unconditional; no further approvals or conditions are required for completion.

• Acceptance timetable – Shareholders intending to tender shares must deliver the completed Form of Acceptance, together with relevant share certificates or transfer receipts, to Computershare Hong Kong Investor Services Limited by 4:00 p.m. on Friday, 8 May 2026. – Consideration cheques, crossed “Not negotiable — account payee only,” will be dispatched within seven business days after the registrar confirms that all required documents have been received.

• Settlement terms – Payment to accepting shareholders will be made in Hong Kong dollars, net of seller’s ad valorem stamp duty. – Shares accepted under the offer will be transferred free of all encumbrances and with all rights attached, including entitlement to dividends or distributions declared on or after 17 April 2026 (the date of the Composite Document).

• Procedural requirements – Joint shareholders must sign the Form of Acceptance collectively. – Overseas shareholders are responsible for ensuring compliance with local regulations, securing any required approvals, and settling any taxes or duties arising from acceptance.

• Disclosure obligations – Personal data provided in the Form of Acceptance will be used for processing the transfer, verifying signatures, maintaining the shareholder register, and meeting statutory disclosure requirements, in accordance with the Personal Data (Privacy) Ordinance.

Shareholders who have already disposed of their Guanze Medical shares are advised to forward the Form of Acceptance and accompanying Composite Document to the new holder or relevant intermediary for further action. The Stock Exchange of Hong Kong, Hong Kong Exchanges and Clearing, and Hong Kong Securities Clearing Company have disclaimed responsibility for the contents of the Form of Acceptance.